Tirzepatide: A Novel, Once-weekly Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes

Gastrointestinal hormones are currently used to treat type 2 diabetes mellitus (T2D). Incretin preparations with gastric inhibitory polypeptide (GIP) activity or glucagon-like peptide-1 (GLP-1) provide new means for controlling blood glucose levels, body weight, and lipid metabolism. GIP, an increti...

Descripción completa

Detalles Bibliográficos
Autor principal: Kaneko, Shizuka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2022
Materias:
Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354517/
https://www.ncbi.nlm.nih.gov/pubmed/35949358
http://dx.doi.org/10.17925/EE.2022.18.1.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354517/
https://www.ncbi.nlm.nih.gov/pubmed/35949358
http://dx.doi.org/10.17925/EE.2022.18.1.10

Ejemplares similares